Ross Osborn Analyst PerformanceDirector, Lead Research Analyst - MedTech and Diagnostics at Cantor FitzgeraldRoss Osborn is a stock analyst at Cantor Fitzgerald focused in the medical sector, covering 15 publicly traded companies. Over the past year, Ross Osborn has issued 19 stock ratings, including strong buy, buy, and hold recommendations. While full access to Ross Osborn's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ross Osborn's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings31 Last 1 YearsBuy Recommendations93.55% 29 Buy RatingsCompanies Covered15 Unique Companies Ratings Distribution31RatingsDistribution of strong buy, buy, hold, and sell ratings by Ross Osborn.RatingPercentageCount Strong Buy6.5%2 ratings Buy87.1%27 ratings Hold6.5%2 ratings Sell0.0%0 ratingsOut of 31 total stock ratings issued by Ross Osborn at Cantor Fitzgerald, the majority (87.1%) have been Buy recommendations, followed by 6.5% Strong Buy and 6.5% Hold.Best & Worst CallsBest Call0000.0%PREJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ELUTMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ15 companiesRoss Osborn, an analyst at Cantor Fitzgerald, currently covers 15 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical13 companies86.7%Manufacturing1 company6.7%Business Services1 company6.7%Ross Osborn of Cantor Fitzgerald specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Business Services companies.Coverage IndustriesIndustryPercentageMED INSTRUMENTS5 companies33.3%MED PRODUCTS4 companies26.7%MED - BIOMED/GENE3 companies20.0%MED - DRUGS1 company6.7%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company6.7%TECHNOLOGY SERVICES1 company6.7% Ross Osborn's Ratings History at Cantor Fitzgerald Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsNPCENeuroPace3/4/2026Upgrade$13.95Strong-Buy$0.0000.00% ROICVRXCVRx2/17/2026Upgrade$4.74Strong-Buy$0.0000.00% ROILMATLeMaitre Vascular11/10/2025Reiterated Rating$86.82$95.00Neutral$0.0000.00% ROICVRXCVRx11/6/2025Boost Price Target$9.76$13.00Overweight$0.0000.00% ROINPCENeuroPace11/5/2025Reiterated Rating$9.40$16.00Overweight$0.0000.00% ROIPREPrenetics Global10/29/2025Boost Price Target$12.53$32.00Overweight$0.0000.00% ROISIBNSiBone8/11/2025Set Price Target$15.68$25.00Overweight$0.0000.00% ROIORGOOrganogenesis8/8/2025Boost Price Target$4.17$9.00Overweight$0.0000.00% ROILMATLeMaitre Vascular8/6/2025Boost Price Target$94.31$95.00Neutral$0.0000.00% ROICVRXCVRx8/5/2025Reiterated Rating$7.55$11.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. SIBNSiBone8/5/2025Reiterated Rating$17.90$25.00Overweight$0.0000.00% ROIMDXGMiMedx Group7/31/2025Boost Price Target$6.52$12.00Overweight$0.0000.00% ROIMDXGMiMedx Group7/15/2025Reiterated Rating$6.80$11.00Overweight$0.0000.00% ROIORGOOrganogenesis7/15/2025Reiterated Rating$4.49$7.00Overweight$0.0000.00% ROIBVSBioventus7/7/2025Initiated Coverage$7.14$12.00Overweight$0.0000.00% ROIXGNExagen5/15/2025Lower Price Target$5.90$7.00Overweight$0.0000.00% ROILUCDLucid Diagnostics5/15/2025Reiterated Rating$1.26$2.00Overweight$0.0000.00% ROINPCENeuroPace5/14/2025Reiterated Rating$14.58$17.00Overweight$0.0000.00% ROISIBNSiBone5/6/2025Reiterated Rating$14.25$25.00Overweight$0.0000.00% ROINNOXNano-X Imaging4/1/2025Lower Price Target$5.03$9.00Overweight$0.0000.00% ROISMTISanara MedTech3/26/2025Reiterated Rating$30.06$46.00Overweight$00.0000.00% ROILUCDLucid Diagnostics3/26/2025Reiterated Rating$1.56$2.00Overweight$0.0000.00% ROIELUTElutia3/7/2025Reiterated Rating$2.46$8.00Overweight$0.0000.00% ROIAXGNAxoGen3/5/2025Reiterated Rating$18.13$24.00Overweight$00.0000.00% ROINPCENeuroPace3/5/2025Boost Price Target$11.22$20.00Overweight$00.0000.00% ROIMDXGMiMedx Group2/27/2025Reiterated Rating$8.24$13.00Overweight$0.0000.00% ROISIBNSiBone2/25/2025Reiterated Rating$19.10$25.00Overweight$00.0000.00% ROICERSCerus2/21/2025Reiterated Rating$1.70$4.00Overweight$0.0000.00% ROISMTISanara MedTech1/22/2025Reiterated Rating$37.31$44.00Overweight$00.0000.00% ROIPREPrenetics Global1/16/2025Reiterated Rating$6.00$9.00Overweight$00.0000.00% ROIXGNExagen1/13/2025Reiterated Rating$3.17$8.00Overweight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
